11 completed, 3 recruiting, 2 not yet recruiting, 1 active not recruiting. 6 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Not yet recruiting 1 |
| Not applicable | 2 | Recruiting 2 |
Follow Thrombosis, Venous: new trials by email Literature Review of Thrombosis, Venous trials Research Report on Thrombosis, Venous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry Recanalization and debulking - Chronic Venous Disease, Chronic Venous Insufficiency, CVI | Not yet recruiting | Intervene, Inc. | 500 | 2026-08-01 | 2026-08-03 | |
| The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients Medication Therapy Management (MTM) model - Thrombosis, Venous | Not applicable | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 327 | 2025-05-01 | 2025-05-31 |
| Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems mechanical thrombectomy of caval and iliofemoral veins - Thrombosis, Venous | Recruiting | IRCCS San Raffaele | 50 | 2025-03-30 | 2025-05-01 | |
| Venous Thrombosis After Removal of Central Venous Catheter Detection of venous thrombosis via US - Thrombosis, Venous | Completed | Meir Medical Center | 50 | 2024-11-01 | 2026-10-09 | |
| The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients Thrombin generation assay - Central Line Complication, Thrombosis, Venous | Terminated | Queen Mary Hospital, Hong Kong | 2 | 2024-04-06 | 2026-09-04 | |
| Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients Edoxaban - Thrombosis, Venous, Cancer | Phase 3 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 366 | 2023-11-30 | 2023-11-29 |
| Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction portable prototype of bioimpedance measurement - Breast Reconstruction, Thrombosis, Venous | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 10 | 2022-12-08 | 2026-06-24 |
| Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study Thrombosis, Venous, Bleeding Hemorrhage | Active not recruiting | Mount Sinai Hospital, Canada | 813 | 2021-11-01 | 2024-11-27 | |
| Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit ultrasound - Central Venous Catheters, Central Venous Catheter Thrombosis | Completed | Policlinico Hospital | 203 | 2020-09-01 | 2023-05-01 | |
| Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism Data collection - Thrombosis, Venous, Colo-rectal Cancer | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 2000 | 2019-01-01 | 2024-07-15 | |
| ARIXTRA® Adherence in SVT Patients. Fondaparinux - Thrombosis, Venous | Completed | GlaxoSmithKline | 1 | 2012-10-01 | 2015-03-27 | |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery dalteparin, enoxaparin, fondaparinux - Thrombosis, Venous | Completed | GlaxoSmithKline | 4068 | 2010-02-01 | 2017-05-16 | |
| Hemorrhage Risk Prescribed Arixtra Fondaparinux sodium, Low molecular weight heparin (LMWH) - Thrombosis, Venous | Completed | GlaxoSmithKline | 13442 | 2010-01-01 | 2015-05-12 | |
| A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery Fondaparinux sodium, Nadroparin - Thrombosis, Venous | Phase 3 | Completed | GlaxoSmithKline | 1351 | 2008-12-01 | 2016-03-16 |
| The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients Fondaparinux sodium, unfractionated heparin (UFH) - Thrombosis, Venous | Phase 3 | Completed | GlaxoSmithKline | 39 | 2008-06-01 | 2016-11-23 |
| Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) Fondaparinux 2.5mg or placebo - Thrombosis, Venous | Phase 3 | Completed | GlaxoSmithKline | 3002 | 2007-03-01 | 2017-03-06 |
| Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer Nadroparin - Thrombosis, Venous | Phase 3 | Completed | GlaxoSmithKline | 503 | 2006-05-01 | 2017-03-23 |
| Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) Fondaparinux - Thrombosis, Venous | Phase 3 | Completed | GlaxoSmithKline | 114 | 2006-01-30 | 2018-09-04 |
Venous Thrombosis (18) · Hemorrhage (3) · Thrombosis (2) · Venous Thromboembolism (2) · Bites and Stings (1) · Blindness, Cortical (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Embolism (1) · Embolism and Thrombosis (1) · Hematologic Neoplasms (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Pulmonary Embolism (1)
Cardiovascular Diseases (18) · Vascular Diseases (18) · Embolism and Thrombosis (17) · Thrombosis (16) · Pathological Conditions, Signs and Symptoms (4) · Neoplasms (3) · Neoplasms by Site (3) · Pathologic Processes (3) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Thromboembolism (2) · Blindness (1) · Blood Platelet Disorders (1)
Fondaparinux (7) · Heparin (2) · Nadroparin (2) · Dalteparin (1) · Data Collection (1) · Enoxaparin (1) · Heparin, Low-Molecular-Weight (1) · Medication Therapy Management (1) · Models, Biological (1) · Ultrasonography (1) · calcium heparin (1) · edoxaban (1) · myotubularin (1)
GlaxoSmithKline (8) · Sixth Affiliated Hospital, Sun Yat-sen University (2) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Centre Hospitalier Universitaire, Amiens (1) · IRCCS San Raffaele (1) · Intervene, Inc. (1) · Meir Medical Center (1) · Mount Sinai Hospital, Canada (1) · Policlinico Hospital (1) · Queen Mary Hospital, Hong Kong (1)
Italy (5) · France (4) · China (3) · Germany (3) · Netherlands (3) · Russia (3) · Canada (2) · Czechia (2) · Hungary (2) · Israel (2) · Poland (2) · Spain (2) · Belgium (1) · Bulgaria (1) · Estonia (1)
Kush R Desai, MD (1) · Sameh Sayfo, MD, MBA (1) · William A Marston, MD (1)
PMID 20860504, PMID 23821661, PMID 35691538, PMID 37981003, PMID 38906793, PMID 41797454